Breast imaging firm TransScan Research and Development of Ramsey, NJ, landed a heavy hitter this month when it hired former Trex Medical chief executive Hal Kirshner as chairman. Kirshner will lead TransScan’s executive team as the company
Breast imaging firm TransScan Research and Development of Ramsey, NJ, landed a heavy hitter this month when it hired former Trex Medical chief executive Hal Kirshner as chairman. Kirshner will lead TransScans executive team as the company moves its T-Scan 2000 electrical impedance imaging system to market. T-Scan 2000 received premarket approval from the Food and Drug Administration last month (SCAN 4/28/99).
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.